摘要:
DNA molecules encoding mutant forms of bone morphogenetic proteins (BMP) are disclosed, The mutant forms of BMP can be produced bacterially and refolded to produce biologically active homodimers or heterodimers of BMP. A method of making such mutant BMPs is also disclosed.
摘要:
Methods, processes, systems, and apparatuses are disclosed for predicting anti-androgen therapy response in the treatment of androgenetic alopecia based on a fluorometric assay and proteomics.
摘要:
The invention provides Sp35 polypeptides and fusion proteins thereof, Sp35 antibodies and antigen-binding fragments thereof and nucleic acids encoding the same. The invention also provides compositions comprising, and methods for making and using, such Sp35 antibodies, antigen-binding fragments thereof, Sp35 polypeptides and fusion proteins thereof.
摘要:
The invention provides Sp35 polypeptides and fusion proteins thereof, Sp35 antibodies and antigen-binding fragments thereof and nucleic acids encoding the same. The invention also provides compositions comprising, and methods for making and using, such Sp35 antibodies, antigen-binding fragments thereof, Sp35 polypeptides and fusion proteins thereof.
摘要:
A method for rating images to facitilate image retrival that includes, storing a plurality of digital image files in a digital memory; displaying the plurality of stored digital image files; permitting a user to select ratings for each of the plurality of displayed images, wherein the rating indicates how much the user likes each displayed image. Whereupon being responsive to the user ratings, user image values are provided for each of the the plurality of displayed images. Additionally, the user image values are stored as metadata in each of the plurality of stored digital image files corresponding to the plurality of displayed images, wherein the user image value uses a multi-point scale and wherein a maximum point value corresponds to a best rating.
摘要:
An image processing system (10) obtains image sequences and assembles a presentation therefrom. The system has a camera (12) for capturing image sequences, a random-access electronic memory (16) for temporary storage of the image sequences, an input reader for accepting pre-programmed instructions from a first storage medium, a control panel with a display (18) for viewing image sequences (64) and presenting pre-programmed instructions to the operator and an operator interface for accepting responses to the pre-programmed instructions. A control logic processor (20) executes pre-programmed instructions and arranges the presentation from the captured image sequences stored in random-access electronic memory (16), according to operator responses. An output writer records the presentation onto a storage medium.
摘要:
This invention provides a fusion molecule comprising a DNA sequence encoding a thioredoxin-like protein fused to the DNA sequence encoding a selected heterologous peptide or protein. The peptide or protein may be fused to the amino terminus of the thioredoxin-like molecule, the carboxyl terminus of the thioredoxin-like molecule, or within the thioredoxin-like molecule, for example at the active-site loop of said molecule. Expression of this fusion molecule under the control of a regulatory sequence capable of directing its expression in a desired host cell, produces high levels of stable and soluble fusion protein. The fusion protein, located in the bacterial cytoplasm, may be selectively released from the cell by osmotic shock or freeze/thaw procedures. It may be optionally cleaved to liberate the soluble, correctly folded heterologous protein from the thioredoxin-like portion.
摘要:
The invention provides Sp35 polypeptides and fusion proteins thereof, Sp35 antibodies and antigen-binding fragments thereof and nucleic acids encoding the same. The invention also provides compositions comprising, and methods for making and using, such Sp35 antibodies, antigen-binding fragments thereof, Sp35 polypeptides and fusion proteins thereof.
摘要:
The invention provides methods of treating diseases, disorsers or injuries involving demyelination and dysmyelination, including multiple sclerosis, by the administration of an Sp35 antagonist.